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Abstract 
 
Chronic widespread pain (CWP) is common and associated with poor general health. There has been no attempt to 
derive a robust prevalence estimate of CWP, or assess how this is influenced by socio-demographic factors. This study 
therefore aimed to determine, through a systematic review and meta-analysis, the prevalence of CWP in the adult 
general population and explore variation in prevalence by age, gender, geographical location and criteria used to 
define CWP. Medline, Embase, CINAHL and AMED were searched using a search strategy combining keywords and 
related database-specific subject terms to identify relevant cohort or cross-sectional studies published since 1990. 
Included papers were assessed for risk of bias. Prevalence figures for CWP (ACR criteria) were stratified according to 
geographical location, age and sex. Potential sources of variation were investigated using subgroup analyses and 
meta-regression. Twenty-five papers met the eligibility criteria. Estimates for CWP prevalence ranged from zero to 
24%, with the majority of estimates between 10 and 15%. The random-effects pooled prevalence was 10.6% (95% CI 
8.6, 12.9). When only studies at low risk of bias were considered pooled prevalence increased to 11.8% (95% CI 10.3, 
13.3), with reduced but still high heterogeneity. Prevalence was higher in women and in those aged 40 years plus. 
There was some limited evidence of geographic variation and cultural differences. One in ten adults in the general 
population report chronic widespread pain with possible socio-cultural variation. The possibility of cultural differences 
in pain reporting should be considered in future research and the clinical assessment of painful conditions. 
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Introduction 
Chronic widespread pain (CWP) is a condition characterized by longstanding diffuse musculoskeletal pain and 
frequently associated with other physical symptoms such as fatigue, psychological distress and concentration 
problems. In the American College of Rheumatology 1990 (ACR-1990) definition [43], CWP is the fundamental feature 
of fibromyalgia (FM) and is defined as pain lasting three months or longer, located axially (cervical spine, thoracic 
spine, anterior chest or low back), above and below the waist, and on the left and right sides of the body. 
In 2010, the ACR published an alternative set of criteria (ACR-2010) [41], meant to be used clinically, which 
emphasized the importance of somatic symptoms (e.g. fatigue, waking unrefreshed) that have been associated with 
FM. The ACR-2010 criteria dispensed with tender-point examination and instead used a measure of the widespread-
ness of pain, and a measure of the number of somatic symptoms experienced, such as fatigue and cognitive 
impairment. The new criteria place FM at one extreme on a spectrum of polysymptomatic distress that includes CWP. 
Whilst studies have reported the prevalence of CWP in different populations, there has been no attempt to 
consolidate these studies to derive a robust prevalence estimate of CWP or to assess how this is influenced by 
sociodemographic factors. There have been three systematic reviews and two narrative reviews of the prevalence of 
‘chronic pain’ [12,30,31,34,38], and one study has summarized the reported prevalence of CWP from 16 population 
studies, but was not a systematic review and did not attempt a meta-analysis [27]. Ascertaining the population 
prevalence of CWP has important public health implications. It is difficult to justify and plan interventions for 
conditions with an unknown community burden. Further, clinicians take into account estimates of disease prevalence 
in different groups of the population (age, sex, ethnicity) when formulating differential diagnoses. Investigating how 
prevalence varies according to features such as age, sex and geographical location offers insights into possible 
aetiology. 
We aimed to systematically review the existing literature that presents estimates for CWP prevalence in the adult 
general population. We chose to limit our review to studies using ACR criteria to define CWP in order to ensure that 
prevalence estimates were comparable. The ACR-1990 criteria were selected as an established and widely used 
measure of CWP diagnosis. However, we also chose to include the more recent ACR-2010 criteria to investigate 
variation in prevalence based on the two ACR CWP case definitions. We explored variation in prevalence estimates by 
age, sex and geographical location. 
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Methods 
Eligibility criteria 
All adult population-based (cross-sectional or cohort) studies published since 1990 where prevalence of CWP was 
presented, or could be calculated from available data, were considered for inclusion. Only studies of CWP determined 
using either the ACR-1990 [43] or ACR-2010 [41] CWP criteria were included. We excluded studies that presented 
estimates based on specific subsets of a general population (for example, women, hospital outpatient clinic patients). 
However, we did not exclude some select populations that were considered to be representative of the general 
population in a particular geographical locale (for example, Pima Indians, Maori population). Full inclusion and 
exclusion criteria are presented in supplementary Table A1 (available online as Supplemental Digital Content at 
http://links.lww.com/PAIN/A138). 
Search strategy 
Medline, Embase, CINAHL and AMED were searched up to 3
rd
 September 2013 using a search strategy combining 
keywords and related database-specific subject terms. The search strategy combined terms related to pain (chronic 
widespread pain, fibromyalgia, chronic pain syndrome, diffuse pain, fibrositis, fibromyositis, myofascial pain), and 
terms related to study design (epidemiology, cohort study, cohort analysis, cross-sectional study, cross-sectional 
analysis, observational analysis, prevalence, disease frequency) (supplementary Tables A2 and A3, available online as 
Supplemental Digital Content at http://links.lww.com/PAIN/A138). 
The titles of the papers returned were examined and any that were obviously irrelevant were excluded. Abstracts and 
then full text of the remaining articles were reviewed to find relevant studies that met the inclusion criteria.  
Additional relevant papers were identified by searching the reference lists of full text articles and hand-searching of 
the Journal of Rheumatology (identified as the most frequent contributor of papers in an initial scoping study). Native 
speakers translated foreign language articles. 
Risk of bias assessment 
Papers included in the study were assessed for risk of bias using two domains of the Quality in Prognosis Studies 
(QUIPS) tool [16] that are relevant to observational studies (1. study participation; 2. outcome measurement). 
Appraisal of each domain provides a subjective assessment of risk of bias (ranked as low, moderate or high). A 
summary of the areas considered in the assessment of each domain is included in the supplementary Table 
A4.1(available online as Supplemental Digital Content at http://links.lww.com/PAIN/A138). 
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Data extraction 
A data extraction form was used to extract equivalent information from each paper. Information extracted included 
population sampled, prevalence estimates, timeframe of prevalence estimate (e.g. point prevalence, annual 
prevalence), and any prevalence estimates reported stratified by age, sex or location. The form also included fields to 
capture data relevant to the assessment of risk of bias. Prevalence figures and 95% confidence intervals (CIs) were 
extracted or calculated from the available data using Wilson’s method [29].  
Reliability 
A second reviewer (KJ) blinded to the primary reviewer’s (KM) decisions checked the paper selection, data extraction 
and risk of bias assessment stages of the review. In each instance the number of papers checked was the larger of 
either 10 studies or 10% of the studies to be appraised. Any differences of opinion were discussed and a third 
reviewer (JS) was available to arbitrate any issues that remained unresolved. 
Analysis 
We undertook an initial descriptive analysis of the studies. Heterogeneity between estimates was assessed using the I
2
 
statistic, which describes the percentage of variation not due to sampling error across studies. An I
2
 value above 75% 
indicates high heterogeneity [18]. We limited the papers included in the meta-analysis to those using the ACR-1990 
criteria to define CWP. Meta-analysis was undertaken using a random-effects model (to account for heterogeneity) 
conducted using the MetaXL (www.epigear.com) add-in for Microsoft Excel. A pooled prevalence figure was 
calculated with 95% CI.  
In a meta-analysis of prevalence, when the estimate for a study tends towards either 0% or 100%, the variance for 
that study moves towards zero and as a result its weight is overestimated in the meta-analysis [5]. Therefore, we 
conducted the meta-analysis with prevalence estimates that had been transformed using the double arcsine method 
[5]. The final pooled result and 95% CIs were back-transformed for ease of interpretation.  
Potential influences on prevalence estimates were investigated using subgroup analyses and meta-regression. Where 
studies allowed, we descriptively compared prevalence estimates by age, gender and location within studies. We then 
assessed the influence on estimates of the following study-level variables identified a priori as potential sources of 
variation in the estimates of prevalence: i) risk of bias; ii) geographical location; and iii) data collection method. We 
classified studies as being either at low risk of bias (low risk of both participation and outcome measurement bias) or 
at moderate-to-high risk of bias (moderate or high risk of either participation or outcome measurement bias). We also 
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compared European studies with North American studies. Data collection method was assessed by comparing studies 
where data were collected by a self-completed questionnaire versus a data collection method that required some 
form of human interaction (e.g. interview or telephone questionnaire). We ran three meta-regression models 
including these covariates separately using Stata version 13.1. 
Results 
Search results 
The search returned a total of 4,051 publications, leading to 111 papers selected for full-text review. An additional 
fifteen studies were identified from the citation lists, and one further paper [28], published after the formal database 
search had been completed, was identified by an electronic citation alert for the ACR-1990 case definition criteria [1]. 
Hence, a total of 127 papers had their full text reviewed for inclusion. The screening process is detailed in Figure 1. 
One hundred and two papers were excluded after full text review. Twenty-five studies (reported in 28 papers) [1–4,6–
11,13–15,19,20,22–26,28,32,33,35,37,39,40,42] were therefore selected for inclusion in the review (Table 1), 
representing 37 CWP prevalence estimates. 
Included studies 
All studies included had a cross-sectional design and estimated point prevalence. Twenty-four studies used ACR-1990 
criteria and the remaining study defined CWP using the ACR-2010 criteria of a widespread pain index of greater than 
or equal to six for a minimum of three months [15]. One study used an unstructured clinical interview [23], the other 
24 used a structured questionnaire. Of the studies using a questionnaire, ten [2,6,10,13,19,25,28,32,37,42] used a 
postal questionnaire, five [1,3,8,35,39] used a telephone questionnaire, three [9,20,22] used a face-to-face interview, 
two [15,33] used a self-completed questionnaire with help available from an interviewer if required, and four 
[11,14,24,40] used a mixture of self-completed questionnaires, face-to-face interviews and telephone questionnaires.  
Risk of bias 
A summary of the risk of bias of the included papers is provided in Table 1; a justification of each rating is provided in 
the supplementary appendix (Table A4.2, available online as Supplemental Digital Content at 
http://links.lww.com/PAIN/A138). Seven studies (29%) were considered to be at low risk of bias for both study 
participation and outcome measurement, and two studies (8%) were considered to be at high risk of bias for both 
domains.   
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Study participation 
Twenty-four percent (n=6) of studies were considered to be at high risk of study participation bias, 44% (n=11) were at 
moderate risk, and 28% (n=7) at low risk (Table 1). One study [40] scored low risk of participation bias for one 
population (Amish) under investigation and moderate risk for another (non-Amish). 
The main failings in sample selection were poor response rates [1,23], non-random sampling of respondents [3,22,23], 
or recruitment from a non-representative sampling frame [11].  
The seven studies at low risk of participation bias either selected their study sample randomly or demonstrated that 
the sample was representative of the study population. Response rates in the low-risk studies were good or these 
studies were able to demonstrate that the sample was representative of the population or that non-responders were 
not significantly different from responders. 
Outcome measurement 
Sixteen percent (n=4) of the papers included were considered to be at high risk of outcome measurement bias, 24% 
(n=6) at moderate risk, and 60% (n=15) at low risk. 
Four studies [1,8,24,33] used non-robust methods to establish prevalence estimates. These prevalence figures were 
calculated from data extrapolated from a sub-sample or from a non-related population (e.g. rheumatology 
outpatients) rather than from the whole sample or the target population. Specifically, i) two studies [1,8] calculated a 
positive predictive value for a screening questionnaire using data obtained from rheumatology outpatients (number 
of confirmed ACR-1990-positive cases in those identified as cases by the questionnaire) and used this to calculate 
prevalence figures using the questionnaire responses from the general population; ii) one study [33] assumed an 
equal frequency of CWP in responders and non-responders and extrapolated prevalence within responders to non-
responders to calculate overall prevalence; and iii) one study [24] calculated prevalence based on examination of a 
stratified sample of positive responders a year after their initial questionnaire response. One paper [33] also failed to 
provide sufficient evidence of validity of their data-collection instrument. 
The 15 studies at low risk of outcome measurement bias used clearly defined diagnostic criteria, reliable and validated 
instruments and a similar method and setting of outcome measurement for all participants. 
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Prevalence 
Prevalence estimates ranged from 0% observed in a sample of Pima Indians [20] to 24% for low socioeconomic status 
populations in Brazil [3]. The majority of estimates were between 10% and 15% of the population, and all the low-risk 
studies using ACR-1990 criteria gave estimates between these two levels. There was greater variation in studies with a 
high risk of bias.  
Low estimates (less than 6%) were found in seven studies [1,14,15,20,23,24,35]. One study [15] used the widespread 
pain index from the ACR-2010 criteria to estimate a CWP prevalence of 5.8%. The remaining six low estimates came 
from studies using the ACE-1990 criteria. One study [24] used a slightly different application of the case definition by 
using data from two different time points a year apart; those with possible widespread pain were identified by an 
initial postal questionnaire and followed up a year later to identify CWP cases. Another [20] estimated prevalence in a 
particularly select population (Pima Indians). Three low estimates [1,23,35] were from studies at high risk of bias. The 
other low estimate [14] may be explained by data collection methods.  
Gender variation 
Fourteen papers presented prevalence figures by gender (Table 2). Prevalence was higher for women in all studies; 
female-to-male prevalence ratios ranged from 1.06 to 4.80, with the majority of estimates showing CWP prevalence in 
women to be around double that observed in men.  
Age variation 
The minimum age for the study population was 18 years or over in all but three of the included studies [8,15,23]. In 
these studies the minimum age was between 12 and 15 years, but estimates from these three studies were within the 
range of those from studies with minimum age of 18 years or over. Six studies presented age-banded data (Figure 2). 
These demonstrate an increase in CWP prevalence to around age 40–50 and then either continually increasing 
prevalence or a plateauing of prevalence estimates in older age groups. Data from Croft et al. [13] demonstrate two 
peaks: one in middle age and another in old age. 
Geographical variation 
Figures for CWP in Europe were generally between 10% and 14% (Table 3). One UK study [25] observed higher 
prevalence in South Asians than Europeans. 
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In North America, prevalence among the Amish was high at 14.5%, compared to 8.9% among rural Ontarians [40], and 
7.3% among urban Ontarians [39]. Pima Indians in Phoenix, Arizona had no observed CWP [20]. The general 
population in the USA was found to have a prevalence of 3.6% in a 2008 study [14] and 10.6% in a 1995 study [42]. 
Four [11,23,25,40] studies made comparisons between different ethnic or cultural groups resident in the same 
regions; all four studies revealed appreciable differences in CWP prevalence.  
Meta-analysis 
Thirty-two prevalence estimates (from 23 papers) were included in the meta-analysis. The 24 papers (36 prevalence 
estimates) using ACR-1990 criteria to estimate CWP prevalence were considered for entry and four estimates (from 
two papers) were excluded. One estimate [24] was excluded because the study population was a subsample of those 
studied in another paper [6]. A further three estimates (from one paper) were excluded to avoid problems with 
overweighting a population; Choudhury et al. [11] presented seven prevalence estimates representing figures for 
different ethnic groups from both a short postal survey and a long questionnaire. Participants were recruited from the 
same sampling frame, which could lead to overlap of study populations; we therefore only included the estimates 
from the short postal survey as the sample was more likely to be representative of the general population.  
The overall random-effects pooled prevalence of CWP was 10.6% (95% CI 8.6, 12.9) with a high level of heterogeneity 
(I
2
 = 98.7%) (Figure 3). When only studies at low risk of bias (on both domains of the QUIPS tool) were considered, the 
pooled prevalence increased to 11.8 (95% CI 10.3, 13.3), with reduced, but still high, heterogeneity (I
2
 = 85.1%). A 
sensitivity analysis using untransformed prevalence estimates showed similar results. 
The results of three meta-regression analyses including pooled estimates for subgroups based on geographical 
location, risk of bias, and data collection method are included in Table 4. There was little evidence of an effect of data 
collection method (p=0.181) or risk of bias (p=0.744) on prevalence. However there was an apparent higher 
prevalence in Europe than North America (12.8% vs. 7.1%, p=0.008). 
Discussion 
Twenty-five papers (37 prevalence estimates) were included in this systematic review and meta-analysis of the 
prevalence of CWP. Prevalence estimates of studies at low risk of bias were between 10% and 15%. Pooled prevalence 
for studies at low risk of bias was 11.8%. Prevalence was higher in women and in those over 40 years of age. There 
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was some evidence of geographic variation in prevalence between Europe and North America. Some papers included 
in the review suggest that there may be sociocultural variation in CWP. 
The review searched four major bibliographic databases, using a search strategy that had been tested in a pilot study, 
and we translated all relevant foreign language articles. In addition, we searched the citation lists of all papers 
selected for full text review and hand searched the Journal of Rheumatology for relevant papers published after 1990. 
Moreover, at each step of the identification and review process a reliability exercise was undertaken. However, we did 
not undertake a search of grey literature, so there may be unpublished research that was not included. Nonetheless, 
with such a large review of a topic, where we could argue that any publication bias is unlikely to be systematic, it 
seems reasonable to conclude that the included studies present a reasonable reflection of the true general population 
prevalence of CWP. 
A systematic review of tools to assess the quality of observational studies examining incidence or prevalence [36] 
concluded that no consensus exists as to which individual criteria should be assessed to establish methodological 
quality. The Cochrane Collaboration [17] advise assessing risk of bias on a subjective basis using domain-based 
evaluation. This advice is also relevant to observational studies. Therefore, based on an evaluation of different tools in 
a pilot study, we chose to use a tool based on a subjective assessment of risk of bias in separate domains [16]. 
However, even guided by a tool, methodological appraisal remains a subjective exercise. For this reason, to minimize 
bias in the review process, for a random sample of 10% of the included papers two reviewers assessed risk of bias 
independently, with minimal disagreement between reviewers. 
No effort was made to contact study authors for raw data. This meant that, in some instances, 95% CIs for prevalence 
estimates had to be calculated from information given in the paper. It also restricted the ability to assess the 
variability in prevalence according to age. Of the papers that presented prevalence figures according to age, the age 
groups used varied. Only one study reported prevalence based on the ACR-2010 criteria; hence, we were unable to 
assess variation between the two ACR criteria definitions. 
Given the varied methodological approaches of the studies included in the review, the appropriateness of calculating 
pooled prevalence estimates could be questioned. Given high heterogeneity between studies, the pooled prevalence 
estimate should therefore be interpreted with caution. However, only studies using the ACR-1990 case definition 
criteria were entered into the meta-analysis, and these criteria were selected as an established and widely used 
standard for CWP/FM diagnosis. Including studies using the same diagnostic criteria in similar populations (male and 
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female adults) ensured some comparability. The heterogeneity in pooled prevalence estimates may have been due to 
data collection method, the geographical location of the study, or bias introduced by study methods. The impact of 
study quality on pooled prevalence was assessed by systematically excluding low-quality studies and studies 
examining particularly select populations from the meta-analysis, and by conducting a meta-regression comparing 
studies at low risk of bias with those at moderate-to-high risk. Meta-regression demonstrated little evidence of data 
collection method or higher risk of bias giving a consistently higher or lower level of prevalence. 
The prevalence estimates of low-risk studies were consistently between 10% and 15%. Prevalence estimates in 
females were around double those for males, whilst prevalence estimates generally plateaued in middle age (40–60 
years). This matches the patterns of prevalence of primary care-recorded widespread pain consultation [21] and non-
specific chronic pain [38]. 
European estimates of prevalence were slightly higher than those from North America. However, the number of North 
American studies was low and only two of these six studies were not in more specific populations. Smaller numbers of 
studies from other locations and diverse methodological approaches make comparisons between other regions 
difficult. There were some apparent cultural and socioeconomic differences in CWP prevalence. The two most 
extreme outliers for CWP prevalence included in the review represent select populations (considered to be 
representative of the general population in the geographical locale from which they were selected) rather than the 
wider general population. The highest estimate for prevalence is for a low socioeconomic population [3], while the 
lowest estimate is in a North American Indian trial population [20].  
Four [11,23,25,40] studies found differences in CWP prevalence between ethnic or cultural groups. Although observed 
differences in prevalence in two of these studies may also be due to different approaches to data collection [40], and 
recruitment [23], this finding may offer some support for ethnic or cultural variation in CWP. Whether any differences 
in the experience of CWP are attributable to lifestyle, genetics or sociocultural influences is unclear and it is difficult to 
draw convincing conclusions based on evidence from only four studies. However, potential cultural differences in pain 
reporting should be considered during clinical history taking, and further research should investigate the extent and 
nature of ethnic, cultural and regional variation in CWP prevalence, as this may offer insights into the aetiology or 
management of this condition. 
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Conclusions 
CWP is a common problem, reported by one in ten adults, with prevalence twice as high in women as in men, and 
with those aged over 40 having a higher prevalence. Heterogeneity between studies made assessment of geographical 
variation difficult. However, there may be cultural differences in CWP prevalence and the possibility of such 
differences in pain reporting should be considered in future research and the clinical assessment of painful conditions. 
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Figures 
 
Figure 1. Flow chart to illustrate the process by which papers were selected or rejected for inclusion in the study. 
 
Figure 2. Variation in CWP prevalence (%) population by age.  
Note that the horizontal axes differ between graphs depending on the information supplied in the corresponding reports. 
 
Figure 3. Forest plot of prevalence (%) of ACR-1990 CWP of studies. Sub-grouped by risk of bias. Random effects 
analysis. 
a. Low-risk studies are those at low risk of bias on both domains of QUIPS tool. 
b. Intermediate-risk studies are those at either moderate risk of bias on both domains or moderate risk in one and low in the other. 
c. High-risk studies are those at high risk of bias on either domain of the QUIPS tool. 
d. Select populations: Pima Indians [20]; Amish population [40]; white European and South Asian [25]. 
SQ: short postal questionnaire 
LQ: long questionnaire 
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Table 1. Summary of studies included, and their risk of participation and outcome measurement bias. 
 
Table 2. Prevalence of CWP in the adult general population stratified by gender. 
 
Table 3. Prevalence of CWP in the adult general population (%) stratified by geographical location. 
 
Table 4. Results of subgroup analyses and three separate meta-regression analyses based on: data collection 
method, geographical location, and risk of bias. 
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Table 1. Summary of studies included, and their risk of participation and outcome measurement bias. 
Study Sample 
size 
Sample 
age 
Location / Population Prevalence % 
(95% CI) 
Risk of study 
participation 
bias  
Risk of outcome 
measurement 
bias 
Ablin et al. 2012 [1] 1,019 18+ Israel 5.1 (3.9, 6.6)* High High 
Aggarwal et al. 2006 [2] 2,299 18–75 Manchester, UK 15.0 (12.3, 16.5)* Low Low 
Assumpção et al. 2009 [3] 768 35–60 São Paulo, Brazil  
(low socioeconomic status) 
24.0 (11.0, 25.0) High Moderate 
Bergman et al 2001 [6,7] 2,425 20–74 Sweden 11.4 (10.1, 12.6) Low Low 
Branco et al. 2010 [4,8] 4,517 15+ Five European countries 13.0 (12.0, 14.0)* Moderate High 
France 1,014  France 10.0 (8.3, 12.0)*   
Italy 1,000  Italy 10.0 (8.3, 12.0)*   
Germany 1,002  Germany 11.0 (9.2, 13.1)*   
Portugal 500  Portugal 13.0 (10.3, 16.2)*   
Spain 1,001  Spain 23.0 (20.5, 25.7)*   
Buskila et al. 2000 [9] 2,210 18+ Israel 10.2 (8.7, 11.1) Low Low 
Carnes et al. 2007 [10] 2,445 18+ South East, UK 12.0 (10.8, 13.3)* Moderate Low 
Choudhury et al. 2013 [11]  18+ Tower Hamlets, London, UK  High Moderate 
Short postal survey 1,223  Short postal survey    
White British/Irish 571  White British/Irish 10.0 (2.0, 18.0)   
British Bangladeshi 141  British Bangladeshi 9.0 (0, 25.0)   
Bangladeshi 201  Bangladeshi 16.0 (3.0, 28.0)   
Other ethnic groups 310  Other ethnic groups 9.0 (0, 20.0)   
Long questionnaire 600  Long questionnaire    
White British/Irish 294  White British/Irish 6.0 (0, 18.0)   
British Bangladeshi 158  British Bangladeshi 9.0 (0, 24.0)   
Bangladeshi 141  Bangladeshi 18.0 (3.0, 33.0)   
Croft et al. 1993 [13] 1,340 18–85 Cheshire, UK 11.2 (9.6, 13.0)* Low Low 
Hardt et al. 2008 [14] 10,271 20+ USA 3.6 (3.1, 4.2) Moderate Moderate 
Häuser et al. 2013** [15] 2,510 14+ Germany 5.8 (5.0, 6.8)* Low Low 
Hunt et al. 1999 [19,26] 1,953 18–65 Manchester, UK (suburban) 12.9 (11.5, 14.5) Low Low 
Jacobsson et al. 1996 [20] 105 35–70 Pima Indians, Gila River Indian 
Community, Phoenix, Arizona, USA 
0 (0, 3.5) Moderate Moderate 
Kim et al. 2006 [22] 1,028 not stated Gyeongsangbook-Do, South Korea 14.0 (12.0, 16.2)* High Moderate 
Klemp et al. 2002 [23] 689 12+ New Zealand 2.8 (1.6, 4.3) High Moderate 
AC
CE
PT
ED
Study Sample 
size 
Sample 
age 
Location / Population Prevalence % 
(95% CI) 
Risk of study 
participation 
bias  
Risk of outcome 
measurement 
bias 
Lindell et al. 2000 [24] 147 18–74 Sweden 4.2 (3.4, 5.0) High High 
Macfarlane et al. 2005 [25]  18–75 UK  Moderate Low 
South Asian 1,945  South Asian 13.8 (12.4, 15.5)*   
White European 932  White European 11.8 (9.9, 14.0)*   
Mundal et al. 2014 [28] 28,367 20+ Norway 17.4 (16.9, 17.8)* Moderate Low 
Papageorgiou et al. 2002 [32] 1,386 27–90 Handforth, UK 10.0 (8.6, 11.7)* Low Low 
Raspe & Baumgartner 1993 [33] 438 25–74 Bad Sackingen, Germany 12.0 (9.4, 15.5) Moderate High 
Scudds et al. 2006 [35] 1,467 18–65 Hong Kong 4.4 (3.4, 5.5)* Moderate Low 
Storozhenko et al. 2004 [37] 120 27–75 Yekaterinburg, Russia 13.3 (8.38, 20.56)* Moderate Low 
White et al. 1999 [39] 3,395 18+ London, Ontario, Canada (urban) 7.3 (6.5, 8.2)*   
White et al. 2003 [40]  18+ Aylmer, Ontario, Canada    
Amish 179  Amish 14.5 (10.1, 20.4)* Low Low 
non-Amish (rural) 494  non-Amish (rural) 8.9 (6.7, 11.8)* Moderate Low 
Wolfe et al. 1995 [42] 3,006 18+ Wichita, USA (urban) 10.6 (9.5, 11.7) Moderate Low 
*95% CI not presented in papers but calculated from sample size and prevalence estimate. 
**Uses ACR-2010 criteria of widespread pain index ≥ 6 for 3 months. 
Risk of bias assessed using Quality in Prognosis Studies (QUIPS) tool [16]. 
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Table 2. Prevalence of CWP in the adult general population, stratified by gender 
 Prevalence % (95% CI) 
Study female male 
female:male 
ratio 
Kim et al. 2006 [22] 19.2 (16.4, 22.4)* 4.0 (2.4, 6.6)* 4.80 
Buskila et al. 2000 [9] 14.0 (12.3, 16.0) 3.0 (2.1, 4.4) 4.67 
Ablin et al. 2012 [1] 7.1 (5.2, 9.7)* 3.0 (1.8, 4.9)* 2.37 
Bergman et al. 2001 [6,7] 15.3 (13.2, 17.4) 7.5 (6.0, 9.1) 1.76 
Klemp et al. 2002 [23] 3.5 (1.9, 5.8) 1.8 (1.0, 4.1) 1.94 
White et al. 1999 [39] 9.0 (7.8, 10.2) 4.7 (3.5, 5.8) 1.91 
Carnes et al. 2007 [10] 14.4 (12.6, 16.4)* 8.2 (6.7, 10.0)* 1.76 
Croft et al. 1993 [13] 15.6 (13.2, 18.4)* 9.4 (7.3, 12.1)* 1.66 
Mundal et al. 2014 [28] 20.7 (20.1, 21.4)* 12.8 (12.3, 13.5)* 1.62 
Aggarwal et al. 2006 [2] 16.0 (14.2, 18.0)* 10.7 (8.9, 12.6)* 1.50 
Hardt et al. 2008 [14] 4.3 (3.5, 5.3) 2.9 (2.3, 3.7) 1.48 
Storozhenko et al. 2004 [37] 14.6 (8.6, 23.9)* 10.5 (4.2, 24.1) 1.39 
Häuser et al. 2013** [15] 6.3 (5.1, 7.7)* 5.3 (4.2, 6.7)* 1.19 
White et al. 2003 (Amish) [40] 14.9 (9.2, 23.1)* 14.0 (8.1, 23.5)* 1.06 
*95% CI not presented in papers but calculated from sample size and prevalence estimate. 
**Uses ACR-2010 criterion of widespread pain index ≥ 6 for 3 months. 
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Table 3. Prevalence of CWP in the adult general population (%), stratified by geographical location 
Geographical region Study Population Prevalence % (95% CI) 
Asia  Scudds et al. 2006 [35] Hong Kong (Chinese population) 4.4 (3.4, 5.5)* 
  Kim et al. 2006 [22] Gyeongsangbook-Do, South Korea 14.0 (12.0, 16.2)* 
Australasia  Klemp et al. 2002 [23] New Zealand 2.8 (1.6, 4.3) 
Middle East  Buskila et al. 2000 [9] Israel 10.2 (8.7, 11.1) 
  Ablin et al. 2012 [1] Israel 5.1 (3.9, 6.6)* 
South America  Assumpção et al. 2009 [3] Sao Paulo, Brazil (low 
socioeconomic status) 
24.0 (21.0, 27.0) 
North America Canada White et al. 2003 [40]   
  Amish Ontario, Canada (Amish) 14.5 (10.1, 20.4)* 
  Non-Amish (rural) Ontario, Canada (rural, non-Amish) 8.9 (6.7, 11.8)* 
  White et al. 1999 [39] London, Ontario, Canada (urban) 7.3 (6.5, 8.2)* 
 USA Jacobsson et al. 1996 [20] Pima Indians, Gila River, Arizona 0 (0, 3.5) 
  Hardt et al. 2008 [14] USA 3.6 (3.1, 4.2) 
  Wolfe et al. 1995 [42] USA 10.6 (9.5, 11.7) 
Europe Papageorgiou et al. 2002 [32] Handforth, UK 10.0 (8.6, 11.7)* 
 Croft et al. 1993 [13] Cheshire, UK 11.2 (9.6, 13.0)* 
 
Central/ 
Western 
Europe Carnes et al. 2007 [10] South East, UK 12.0 (10.8, 13.3)* 
  Choudhury et al. 2013 [11] East London, UK  
  Short postal survey White British/Irish 10.0 (2.0, 18.0) 
   British Bangladeshi 9.0 (0, 25.0) 
   Bangladeshi 16.0 (3.0, 28.0) 
   Other ethnic groups 9.0 (0, 20.0) 
  Long questionnaire White British/Irish 6.0 (0, 18.0) 
   British Bangladeshi 9.0 (0, 24.0) 
   Bangladeshi 18.0 (3.0, 33.0) 
  Hunt et al. 1999 [19,26] Manchester, UK 12.9 (11.5, 14.5) 
  Macfarlane et al. 2005 [25] Bolton, Oldham, Aston, Tameside 
and Birmingham, UK 
 
  White European  11.8 (9.9, 14.0)* 
  South Asian  13.8 (12.4, 15.5)* 
  Aggarwal et al. 2006 [2] Manchester, UK 15.0 (12.3, 15.1)* 
  Raspe & Baumgartner 1993 [33] Bad Sackingen, Germany 12.0 (9.4, 15.5) 
  Häuser et al. 2013** [15] Germany 5.8 (5.0, 6.8)* 
  Branco et al. 2010 [4,8] Europe 13.0 (12.0, 14.0)* 
   France 10.0 (8.3, 12.0)* 
   Italy 10.0 (8.3, 12.0)* 
   Germany 11.0 (9.2, 13.1)* 
   Portugal 13.0 (10.3, 16.2)* 
   Spain 23.0 (20.5, 25.7)* 
 Scandinavia Lindell et al. 2000 [24] Halmstad & Laholm, Sweden 4.2 (3.4, 5.0) 
  Bergman et al. 2001 [6,7] Halmstad & Laholm, Sweden 11.4 (10.1, 12.6) 
  Mundal et al. 2014 [28] Norway 17.4 (16.9, 17.8)* 
 Russia Storozhenko et al. 2004 [37] Yekaterinburg, Russia 13.3 (8.38, 2.56)* 
*95% CI not presented in papers but calculated from sample size and prevalence estimate. 
**Uses ACR-2010 criterion of widespread pain index ≥ 6 for 3 months. 
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Table 4. Results of subgroup analyses and three separate meta-regression analyses based on: data collection 
method, geographical location, and risk of bias. 
 Subgroup analyses Meta-regression 
 Number of 
estimates 
Pooled estimate 
(95% CI) 
I
2 
(%) 
Mean 
difference  
(95% CI) 
p-value 
All estimates 32 10.6 (8.6, 12.9) 98.7   
Data collection method    -2.4 (-6.0, 1.19) 0.181 
Self-complete 16 12.6 (10.7, 14.5) 95.1   
Human interaction 
(interview/questionnaire) 
16 9.8 (7.5, 12.1) 97.7   
Location    5.1 (1.5, 8.7) 0.008 
North America (USA, Canada) 6 7.1 (4.0, 10.2) 97.5   
Europe 20 12.8 (11.1, 14.5) 94.7   
Risk of bias*    0.8 (-4.0, 5.5) 0.744 
Moderate/high risk 26 10.9 (8.3, 13.6) 98.9   
Low risk 6 11.8 (10.3, 13.3) 85.7   
* Low risk of bias: low risk on both participation bias and outcome measurement bias domains of the QUIPS tool; Moderate/high risk of bias: 
moderate or high risk of bias on a either participation bias or outcomecome measurement bias domains of the QUIPS tool. 
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Medline
1,227
AMED
500
Embase
1,679
CINAHL
645
Total
4,051
Search results combined 
and duplicates excluded
2,818
Titles screened
2,818
Records excluded after 
review of titles
2,482
Studies excluded after review of 
full text (n=102)
• Prevalence figures for CWP are 
not stated or cannot be 
calculated from the available 
information (n=63)
• Present prevalence figures for 
groups other than mixed-sex 
adults (n=13)
• Use CWP case definition other 
than ACR (n=5)
• Review articles (n=5)
• Editorial or letter (n=5)
• Study population not 
representative of the general 
population (n=6)
• Study documented in another 
paper included in the review 
(n=3)
• Study not cross-sectional or 
cohort (n=2)
Additional studies 
identified (n=16)
• Studies identified 
from citation lists 
(n=15)
• Study identified 
incidentally (n=1)
Abstracts screened
336
Records excluded after 
review of abstracts
225
Full text screened on the 
basis of title and 
abstract
111 + 16 = 127
Papers included in 
qualitative synthesis
25
Papers included in quantitative 
synthesis (meta-analysis)
23
23 papers = 32 prevalence 
Papers excluded from 
quantitative synthesis
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